Please login to the form below

Not currently logged in
Email:
Password:

Postpartum depression

This page shows the latest Postpartum depression news and features for those working in and with pharma, biotech and healthcare.

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen and Sage signed a $3.1bn deal last year to jointly develop potential depression therapies. ... for postpartum depression and other psychiatric disorders.

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...